We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is calling out a Taiwanese drugmaker for a slew of GMP violations circling its quality control unit's written procedures, rendering its products adulterated. Read More
Citing the nation’s opioid epidemic, the two top members of the Senate Special Committee on Aging have written to five different drugmakers inquiring about their efforts to improve access to opioid rescue drug naloxone. Read More
A district court judge has spared Gilead from paying a hefty sum in damages to Merck over a HCV patent dispute, overturning a March San Jose federal jury ruling. Read More